80
Correspondence concerning this article can be sent directly to the authors through the emails:
References:
1. Novotny HR, Alvis DL. A method of photographing fluorescence in
circulating blood in the human retina. Circulation 1961; 24: 82-86.
2. Wolfe DR. Fluorescein angiography: basic science and engineer-
ing. Ophthalmology 1986; 93: 1617-1620.
3. Yannuzzi LA, Rohrer KT, Tindel LJ, et al. Fluorescein angiography
complication survey. Ophthalmology 1986; 93: 611-617.
4. Jumper JM, Fu AD, McDonald HR, Johnson RN, Ai E. Fluores-
cein angiography. In : Alfaro DV, Liggett PE, Mieler WF, Quiroz-
Mercado H, Jager RD, Tano Y, eds. Age-related macular degenera-
tion. Lippincott Williams&Wilkins; Philadelphia 2006: 86-100.
5. Spaide RF. Fundus angiography. In: Holz FG, Pauleikhoff D,
Spaide RF, Bird AC, eds. Age-related macular degeneration.
Springer; Heidelberg 2004: 87-107.
6. Bressler NM, Bressler SB, Fine SL. Age-related macular degenera-
tion. Surv Ophthalmol 1988; 32: 375-413.
7. Pauleikhoff D, Zuels S, Sheraidah GS, et al. Correlation between
biochemical composition and fluorescein binding of deposits in
Bruch’s membrane. Ophthalmology 1992; 99: 1548-1553.
8. Spaide RF. Fundus autofluorescence and age-related macular de-
generation. Ophthalmology 2003; 110: 392-399.
9. Pieramici DJ, Bressler SB. Fluorescein angiography. In: Berger JW,
Fine SL, Maguire MG, eds. Age-related macular degeneration.
Mosby; St. Louis: 219-236.
10. Gass JDM. Pathogenesis of disciform detachment of the neuroepi-
thelium. Am J Ophthalmol 1967; 63: 567-659.
11. Bressler NM, Bressler SB, Alexander J, et al. Loculated fluid. A
previously undescribed fluorescein angiographic finding in choroi-
dal neovascularization associated with macular degeneration. Mac-
ular Photocoagulation Study Reading Center. Arch Ophthalmol
1991; 109: 211-215.
12. Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy
of subfoveal choroidal neovascularization with verteporfin: fluores-
cein angiographic guidelines for evaluation and treatment – TAP
and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-1268.
13. Macular Photocoagulation Study Group. Subfoveal neovascular
lesions in age-related macular degeneration. Guidelines for evalu-
ation and treatment in the macular photocoagulation study. Arch
Ophthalmol 1991; 109: 1242-1257.
14. Gass JDM. Serous retinal pigment detachment with a notch. Ret-
ina 1984; 4: 205-220.
15. Coscas G, Koenig F, Soubrane G. The pretear characteristics of
pigment epithelial detachments. A study of 40 eyes. Arch Oph-
thalmol 1990; 108: 1687-1693.
16. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous pro-
liferation in age-related macular degeneration. Retina 2001; 21:
416-434.
17. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal
choroidal vasculopathy. Retina 1990 ; 10 : 1-8.
18. Arias L, Caminal J, Rubio M, et al. Retinal pigment epithelial
tears after intravitreal bevacizumab injection for predominantly
classic choroidal neovascularization. Eur J Ophthalmol 2007; 17:
992-995.
19. Verteporfin Roundtable Participants. Guidelines for using verte-
porfin (Visudyne) in photodynamic therapy for choroidal neovas-
cularization due to age-related macular degeneration and other
causes: update. Retina 2005; 25: 119-134.
20. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence
tomography-guided, variable dosing regimen with intravitreal
ranibizumab (Lucentis) for neovascular age-related macular de-
generation. Am J Ophthalmol 2007; 143: 566-83.
